Fucheng Yin

Progress in approved drugs from natural product resources

Zhongwen Luo, Fucheng Yin, Xiaobing Wang et al. · Chinese Journal of Natural Medicines · 2024 · 189 citations

Medicinal Chemistry, Green Pharmacy, Medicine +5

Discovery of First-in-Class Dual PARP and EZH2 Inhibitors for Triple-Negative Breast Cancer with Wild-Type BRCA

Chéng Wáng, Lailiang Qu, Shang Li et al. · Journal of Medicinal Chemistry · 2021 · 96 citations · Full text

Development of a Tau-Targeted Drug Delivery System Using a Multifunctional Nanoscale Metal–Organic Framework for Alzheimer’s Disease Therapy

Jinhua Zhao, Fucheng Yin, Limei Ji et al. · ACS Applied Materials & Interfaces · 2020 · 76 citations

Discovery of precision targeting EZH2 degraders for triple-negative breast cancer

Cheng Wang, Xinye Chen, Xingchen Liu et al. · European Journal of Medicinal Chemistry · 2022 · 54 citations

Systems Biology, Oncology, Engineering +11

Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease

Xiaobing Wang, Fucheng Yin, Ming Huang et al. · RSC Medicinal Chemistry · 2020 · 47 citations · Full text